Literature DB >> 33807722

Drug Discovery in Liver Disease Using Kinome Profiling.

Bingting Yu1, Ruslan Mamedov1, Gwenny M Fuhler1, Maikel P Peppelenbosch1.   

Abstract

The liver is one of the most important organs, playing critical roles in maintaining biochemical homeostasis. Accordingly, disease of the liver is often debilitating and responsible for untold human misery. As biochemical nexus, with kinases being master regulators of cellular biochemistry, targeting kinase enzymes is an obvious avenue for treating liver disease. Development of such therapy, however, is hampered by the technical difficulty of obtaining comprehensive insight into hepatic kinase activity, a problem further compounded by the often unique aspects of hepatic kinase activities, which makes extrapolations from other systems difficult. This consideration prompted us to review the current state of the art with respect to kinome profiling approaches towards the hepatic kinome. We observe that currently four different approaches are available, all showing significant promise. Hence we postulate that insight into the hepatic kinome will quickly increase, leading to rational kinase-targeted therapy for different liver diseases.

Entities:  

Keywords:  hepatitis; hepatocellular carcinoma; hepatocytes; kinases; kinome; liver; peptide arrays

Mesh:

Substances:

Year:  2021        PMID: 33807722      PMCID: PMC7961955          DOI: 10.3390/ijms22052623

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  144 in total

Review 1.  Pathogenesis of Cholangiocarcinoma.

Authors:  Pedro M Rodrigues; Paula Olaizola; Nuno A Paiva; Irene Olaizola; Alona Agirre-Lizaso; Ana Landa; Luis Bujanda; Maria J Perugorria; Jesus M Banales
Journal:  Annu Rev Pathol       Date:  2020-12-02       Impact factor: 23.472

Review 2.  Molecular perspectives for the treatment of hepatocellular carcinoma.

Authors:  A Demory; J C Nault
Journal:  Acta Gastroenterol Belg       Date:  2020 Apr-Jun       Impact factor: 1.316

3.  Predicting the future burden of NAFLD and NASH.

Authors:  Suzanne E Mahady; Jacob George
Journal:  J Hepatol       Date:  2018-07-17       Impact factor: 25.083

Review 4.  Pharmacologic Management of Portal Hypertension.

Authors:  Chalermrat Bunchorntavakul; K Rajender Reddy
Journal:  Clin Liver Dis       Date:  2019-08-07       Impact factor: 6.126

5.  Elevated Src expression associated with hepatocellular carcinoma metastasis in northern Chinese patients.

Authors:  Ran Zhao; Yiqi Wu; Tianzhen Wang; Yuhua Zhang; Dan Kong; Lei Zhang; Xiaobo Li; Guangyu Wang; Yinji Jin; Xiaoming Jin; Fengmin Zhang
Journal:  Oncol Lett       Date:  2015-09-16       Impact factor: 2.967

6.  The role of Tec kinase signaling pathways in the development of Mallory Denk Bodies in balloon cells in alcoholic hepatitis.

Authors:  N Afifiyan; B Tillman; B A French; O Sweeny; M Masouminia; S Samadzadeh; S W French
Journal:  Exp Mol Pathol       Date:  2017-09-19       Impact factor: 3.362

7.  Cloning and expression of two human p70 S6 kinase polypeptides differing only at their amino termini.

Authors:  J R Grove; P Banerjee; A Balasubramanyam; P J Coffer; D J Price; J Avruch; J R Woodgett
Journal:  Mol Cell Biol       Date:  1991-11       Impact factor: 4.272

8.  HEV ORF3 downregulates TLR7 to inhibit the generation of type I interferon via impairment of multiple signaling pathways.

Authors:  Qingsong Lei; Lin Li; Shujun Zhang; Tianju Li; Xiaomei Zhang; Xiaolin Ding; Bo Qin
Journal:  Sci Rep       Date:  2018-06-05       Impact factor: 4.379

9.  A Direct Effect of Sex Hormones on Epithelial Barrier Function in Inflammatory Bowel Disease Models.

Authors:  Janine van der Giessen; C Janneke van der Woude; Maikel P Peppelenbosch; Gwenny M Fuhler
Journal:  Cells       Date:  2019-03-19       Impact factor: 6.600

Review 10.  Tissue-Resident Memory T Cells in the Liver-Unique Characteristics of Local Specialists.

Authors:  Lea M Bartsch; Marcos P S Damasio; Sonu Subudhi; Hannah K Drescher
Journal:  Cells       Date:  2020-11-11       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.